Medtronic Gets U.S. Approval For First Artificial Pancreas System

(RTTNews) - Medical device maker Medtronic, Inc. (MDT) Friday announced that it has won the U.S. Food and Drug Administration, or FDA approval for its first-generation artificial pancreas system with Threshold Suspend automation for people with diabetes.

According to the company, the MiniMed 530G with Enlite is the first in the US that can automatically stop insulin delivery when sensor glucose values reach a preset level and when the patient does not respond to the Threshold Suspend alarm.

The company noted that MiniMed 530G system is Medtronic's most accurate and comfortable continuous glucose sensor with a 31 percent improvement in overall accuracy from the previous generation.

The system was approved for use by people with diabetes ages 16 and older.